Copyright
©The Author(s) 2017.
World J Gastroenterol. Feb 28, 2017; 23(8): 1469-1476
Published online Feb 28, 2017. doi: 10.3748/wjg.v23.i8.1469
Published online Feb 28, 2017. doi: 10.3748/wjg.v23.i8.1469
n = 864 | |
Age (yr) | 67 (61- 72) |
≥ 67 yr | 432 (50.0) |
Gender male | 678 (78.5) |
Anti-HCV positive | 538 (62.3) |
HBsAg positive | 197 (22.8) |
Alcohol/other | 120 (13.9) |
Creatinine (mg/dL) | 0.90 (0.80-1.04) |
Albumin (g/L) | 4.0 (3.7-4.3) |
Bilirubin (mg/dL) | 0.85 (0.64-1.19) |
INR | 1.13 (1.07-1.22) |
Platelet count (× 103/mL) | 142 (102-186) |
< 100.000/mL | 202 (23.4) |
MELD score | 9 (8-10) |
< 9 | 428 (49.5) |
9-10 | 298 (34.5) |
> 10 | 138 (16.0) |
Oesophageal varices | 216 (25.0) |
Tumour size (cm) | 3.5 (2.3-5.0) |
Single nodule | 676 (78.2) |
UNOS Stage | |
T1 | 84 (9.7) |
T2 | 527 (61.0) |
T3 | 237 (27.4) |
T4a | 16 (1.9) |
Extension of hepatectomy | |
Wedge/segmentectomy | 625 (72.3) |
Bisegmentectomy | 146 (16.9) |
Three or more segments | 93 (10.8) |
- Citation: Cucchetti A, Sposito C, Pinna AD, Citterio D, Cescon M, Bongini M, Ercolani G, Cotsoglou C, Maroni L, Mazzaferro V. Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients. World J Gastroenterol 2017; 23(8): 1469-1476
- URL: https://www.wjgnet.com/1007-9327/full/v23/i8/1469.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i8.1469